Universidade Federal de São Paulo, GRAACC, Pediat Oncol Inst, São Paulo, BrazilUniversidade Federal de São Paulo, Dept Pathol, São Paulo, BrazilUniversidade Federal de São Paulo, GRAACC, Pediat Oncol Inst, São Paulo, BrazilUniversidade Federal de São Paulo, Dept Pathol, São Paulo, BrazilWeb of Scienc
Busulfan (Bu) is a common component of conditioning regimens before hematopoietic stem cell transpla...
AbstractWe conducted a retrospective pharmacokinetic analysis of i.v. busulfan in children undergoin...
Unrelated umbilical cord blood transplantation (UCBT) is an alternative to provide transplants in ch...
AbstractWe studied 30 pediatric patients with malignant (n = 16) or nonmalignant (n = 14) conditions...
AbstractWe investigated the pharmacokinetics (PK) of a recently approved intravenous busulfan (IVBU)...
AbstractAchievement of a busulfan area-under-the-concentration versus time curve (AUC) of 900 to 150...
AbstractAchievement of a busulfan area-under-the-concentration versus time curve (AUC) of 900 to 150...
β-thalassemia is a major health problem worldwide, and stem cell transplantation (SCT) is the only c...
AbstractBusulfan (Bu) is widely used in conditioning regimens for infants undergoing allogeneic hema...
AbstractWe studied 30 pediatric patients with malignant (n = 16) or nonmalignant (n = 14) conditions...
AbstractWe currently calculate area under the busulfan concentration time curve (AUC) using 7 plasma...
AbstractBusulfan, combined with therapeutic drug monitoring–guided dosing, is associated with higher...
AbstractWe investigated the pharmacokinetics (PK) of a recently approved intravenous busulfan (IVBU)...
β-thalassemia is a major health problem worldwide, and stem cell transplantation (SCT) is the only c...
β-thalassemia is a major health problem worldwide, and stem cell transplantation (SCT) is the only c...
Busulfan (Bu) is a common component of conditioning regimens before hematopoietic stem cell transpla...
AbstractWe conducted a retrospective pharmacokinetic analysis of i.v. busulfan in children undergoin...
Unrelated umbilical cord blood transplantation (UCBT) is an alternative to provide transplants in ch...
AbstractWe studied 30 pediatric patients with malignant (n = 16) or nonmalignant (n = 14) conditions...
AbstractWe investigated the pharmacokinetics (PK) of a recently approved intravenous busulfan (IVBU)...
AbstractAchievement of a busulfan area-under-the-concentration versus time curve (AUC) of 900 to 150...
AbstractAchievement of a busulfan area-under-the-concentration versus time curve (AUC) of 900 to 150...
β-thalassemia is a major health problem worldwide, and stem cell transplantation (SCT) is the only c...
AbstractBusulfan (Bu) is widely used in conditioning regimens for infants undergoing allogeneic hema...
AbstractWe studied 30 pediatric patients with malignant (n = 16) or nonmalignant (n = 14) conditions...
AbstractWe currently calculate area under the busulfan concentration time curve (AUC) using 7 plasma...
AbstractBusulfan, combined with therapeutic drug monitoring–guided dosing, is associated with higher...
AbstractWe investigated the pharmacokinetics (PK) of a recently approved intravenous busulfan (IVBU)...
β-thalassemia is a major health problem worldwide, and stem cell transplantation (SCT) is the only c...
β-thalassemia is a major health problem worldwide, and stem cell transplantation (SCT) is the only c...
Busulfan (Bu) is a common component of conditioning regimens before hematopoietic stem cell transpla...
AbstractWe conducted a retrospective pharmacokinetic analysis of i.v. busulfan in children undergoin...
Unrelated umbilical cord blood transplantation (UCBT) is an alternative to provide transplants in ch...